204 related articles for article (PubMed ID: 20719937)
1. The D prostanoid receptor agonist BW245C [(4S)-(3-[(3R,S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidineheptanoic acid] inhibits fibroblast proliferation and bleomycin-induced lung fibrosis in mice.
van den Brule S; Wallemme L; Uwambayinema F; Huaux F; Lison D
J Pharmacol Exp Ther; 2010 Nov; 335(2):472-9. PubMed ID: 20719937
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice.
Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of lipoxin A4 receptor by thromboxane A2 signaling in RAW246.7 cells in vitro and bleomycin-induced lung fibrosis in vivo.
Sato Y; Kitasato H; Murakami Y; Hashimoto A; Endo H; Kondo H; Inoue M; Hayashi I
Biomed Pharmacother; 2004; 58(6-7):381-7. PubMed ID: 15271420
[TBL] [Abstract][Full Text] [Related]
4. Activation of somatostatin receptors attenuates pulmonary fibrosis.
Borie R; Fabre A; Prost F; Marchal-Somme J; Lebtahi R; Marchand-Adam S; Aubier M; Soler P; Crestani B
Thorax; 2008 Mar; 63(3):251-8. PubMed ID: 17951277
[TBL] [Abstract][Full Text] [Related]
5. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
[TBL] [Abstract][Full Text] [Related]
6. [The therapeutic effect of TGF-beta monoclonal antibody to bleomycin-induced pulmonary fibrosis in rats].
Li J; He B; Weng B
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):347-9. PubMed ID: 10374444
[TBL] [Abstract][Full Text] [Related]
7. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
[TBL] [Abstract][Full Text] [Related]
8. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice.
Shen Y; Zhao HL; Du J; Li YT; Tan F; Huang CG; Pei G
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1071-7. PubMed ID: 16445573
[TBL] [Abstract][Full Text] [Related]
9. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G
J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567
[TBL] [Abstract][Full Text] [Related]
10. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B
J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663
[TBL] [Abstract][Full Text] [Related]
11. Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice.
Kinoshita K; Aono Y; Azuma M; Kishi J; Takezaki A; Kishi M; Makino H; Okazaki H; Uehara H; Izumi K; Sone S; Nishioka Y
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):536-43. PubMed ID: 23642017
[TBL] [Abstract][Full Text] [Related]
12. Effect of Feitai on bleomycin-induced pulmonary fibrosis in rats.
Gong LK; Li XH; Wang H; Zhang L; Chen FP; Cai Y; Qi XM; Liu LL; Liu YZ; Wu XF; Huang CG; Ren J
J Ethnopharmacol; 2005 Jan; 96(3):537-44. PubMed ID: 15619575
[TBL] [Abstract][Full Text] [Related]
13. The role of high mobility group box1 in pulmonary fibrosis.
Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y
Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281
[TBL] [Abstract][Full Text] [Related]
14. Effects of prostaglandin D(2) and 5-lipoxygenase products on the expression of CD203c and CD11b by basophils.
Monneret G; Boumiza R; Gravel S; Cossette C; Bienvenu J; Rokach J; Powell WS
J Pharmacol Exp Ther; 2005 Feb; 312(2):627-34. PubMed ID: 15388786
[TBL] [Abstract][Full Text] [Related]
15. [Effects of interleukin-17 on murine pulmonary fibroblast proliferation, transformation and collagen synthesis].
Dong Z; Kang Q; Lei W; Zhong H; Tai W; Wang D
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jan; 32(1):75-9. PubMed ID: 22366009
[TBL] [Abstract][Full Text] [Related]
16. [The pivotal role of CXCR3 in the pathogenesis of bleomycin-induced pulmonary fibrosis].
Gao JM; Lu B
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):28-32. PubMed ID: 15774188
[TBL] [Abstract][Full Text] [Related]
17. Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters.
Wang Q; Hyde DM; Gotwals PJ; Giri SN
Exp Lung Res; 2002 Sep; 28(6):405-17. PubMed ID: 12217209
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10.
Tager AM; Kradin RL; LaCamera P; Bercury SD; Campanella GS; Leary CP; Polosukhin V; Zhao LH; Sakamoto H; Blackwell TS; Luster AD
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):395-404. PubMed ID: 15205180
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of bleomycin-induced pulmonary fibrosis by follistatin.
Aoki F; Kurabayashi M; Hasegawa Y; Kojima I
Am J Respir Crit Care Med; 2005 Sep; 172(6):713-20. PubMed ID: 15976370
[TBL] [Abstract][Full Text] [Related]
20. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice.
Gurujeyalakshmi G; Wang Y; Giri SN
J Pharmacol Exp Ther; 2000 Apr; 293(1):82-90. PubMed ID: 10734156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
